A retrospective cohort study investigates the association between a newly approved oral Janus kinase (JAK) inhibitor and the incidence of major adverse cardiovascular events (MACE) in adult patients with severe rheumatoid arthritis. The comparison group consists of patients treated with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs). Over a 3-year follow-up period, the crude relative risk of MACE for patients taking the JAK inhibitor compared to those taking csDMARDs is ( CI, ; ).
Concerned about baseline differences between the groups, the investigators perform a stratified analysis based on a history of tobacco smoking. The results of the stratified analysis are shown below:
| Smoking Status | Relative Risk of MACE ( CI) |
|---|---|
| Active or former smokers | () |
| Never smokers | () |
Based on these findings, which of the following is the most accurate epidemiological conclusion regarding a history of tobacco smoking in this study?
- It acts as a confounding variable because the stratum-specific relative risks are similar to each other but differ from the crude estimate.Answer
- BIt acts as an effect modifier because the stratum-specific relative risks are similar to each other but differ from the crude estimate.
- CIt acts as an effect modifier because the overall significant association disappears upon stratification.
- DIt acts as a confounding variable because the unadjusted relative risk is statistically significant prior to stratification.
- EIts influence on the study outcomes invalidates the results because an inferential statistical test should have been used instead of stratification.